Institute of Neurosurgery, University and City Hospital, Verona, Italy.
Section of Vascular Neurosurgery, Institute of Neurological Surgery, University and City Hospital, Verona, Italy.
J Clin Neurosci. 2024 May;123:162-170. doi: 10.1016/j.jocn.2024.04.001. Epub 2024 Apr 5.
Features associated with a safe surgical resection of cerebral cavernous malformations (CMs) are still not clear and what is needed to achieve this target has not been defined yet.
Clinical presentation, radiological features and anatomical locations were assessed for patients operated on from January 2008 to January 2018 for supratentorial and cerebellar cavernomas. Supratentorial CMs were divided into 3 subgroups (non-critical vs. superficial critical vs. deep critical). The clinical outcome was assessed through modified Rankin Scale (mRS) and was divided into favorable (mRS 0-1) and unfavorable (mRS ≥ 2). Post-operative epilepsy was classified according to the Maraire Scale.
A total of 144 were considered eligible for the current study. At 6 months follow-up the clinical outcome was excellent for patients with cerebellar or lobar CMs in non-critical areas (mRS ≤ 1: 91.1 %) and for patients with superficial CMs in critical areas (mRS ≤ 1: 92.3 %). Patients with deep-seated suprantentorial CMs showed a favorable outcome in 76.9 %. As for epilepsy 58.5 % of patients presenting with a history of epilepsy were free from seizures and without therapy (Maraire grade I) at last follow-up (mean 3.9 years) and an additional 41.5 % had complete control of seizures with therapy (Maraire grade II).
Surgery is safe in the management of CMs in non-critical but also in critical supratentorial locations, with a caveat for deep structures such as the insula, the basal ganglia and the thalamus/hypothalamus.
与脑动静脉畸形(CMs)安全手术切除相关的特征尚不清楚,尚未明确实现这一目标所需的条件。
评估了 2008 年 1 月至 2018 年 1 月期间接受幕上和小脑动静脉畸形手术的患者的临床表现、影像学特征和解剖位置。幕上 CMs 分为 3 个亚组(非关键 vs. 浅表关键 vs. 深部关键)。通过改良 Rankin 量表(mRS)评估临床结果,并分为良好(mRS 0-1)和不良(mRS≥2)。术后癫痫根据 Maraire 量表分类。
共有 144 例患者符合当前研究标准。6 个月随访时,小脑或脑叶非关键部位 CMs 患者(mRS≤1:91.1%)和浅表关键部位 CMs 患者(mRS≤1:92.3%)的临床结果极好。深部幕上 CMs 患者的预后良好率为 76.9%。至于癫痫,58.5%有癫痫病史的患者在末次随访(平均 3.9 年)时无发作且无需治疗(Maraire 分级 I),另有 41.5%的患者通过治疗完全控制了癫痫发作(Maraire 分级 II)。
手术治疗非关键部位但也包括关键部位的 CMs 是安全的,但是对于脑岛、基底节和丘脑/下丘脑等深部结构要谨慎。